Pictet Asset Management (Switzerland)’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $31.3M | Buy |
1,307,540
+425,265
| +48% | +$10.2M | 0.04% | 368 |
|
|
2023
Q1 | $16.6M | Buy |
882,275
+577,731
| +190% | +$10.9M | 0.02% | 502 |
|
|
2022
Q4 | $4.85M | Buy |
304,544
+81,948
| +37% | +$1.3M | 0.01% | 742 |
|
|
2022
Q3 | $3.64M | Sell |
222,596
-625,368
| -74% | -$10.2M | 0.01% | 801 |
|
|
2022
Q2 | $11.9M | Buy |
847,964
+395,959
| +88% | +$5.58M | 0.02% | 560 |
|
|
2022
Q1 | $10.9M | Buy |
452,005
+323,414
| +252% | +$7.83M | 0.01% | 626 |
|
|
2021
Q4 | $3M | Hold |
128,591
| – | – | ﹤0.01% | 928 |
|
|
2021
Q3 | $2.14M | Buy |
+128,591
| New | +$2.14M | ﹤0.01% | 983 |
|